Hepatitis C Medicines from India

Hepatitis C is now curable. Direct-acting antivirals (DAAs) cure more than 95% of patients in 12 weeks of tablets, with no interferon injections. This page lists the Indian generic hepatitis C medicines available at U-India.

Sofosbuvir + Velpatasvir (pan-genotypic, generic Epclusa)

• Velakast — from $400 per pack.
• Sovihep V — from $400.
• Velasof — from $420.

Sofosbuvir + Daclatasvir

• Sofokast and Dacikast — from $250.
• MyHep and MyDekla — from $250.
• SoviHep and DaciHep — from $250.

Sofosbuvir + Ledipasvir (genotype 1, generic Harvoni)

• Myhep LVIR — from $180.
• Ledikast — from $270.

The regimen is chosen by a physician: viral genotype, presence of cirrhosis, prior treatment, kidney function, and drug interactions. A standard course is 12 weeks (usually 3 packs). Cure is confirmed by PCR 12 weeks after therapy ends.

This information is educational and does not replace medical advice. All medicines are prescription-only.